According to a market report by Lucintel, the future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7.0 billion by 2030 from $2.7 billion in 2024,at a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.
A more than 150-page report to understand trends, opportunity and forecast in cloning and mutagenesis market to 2030 by product (cloning kits, mutagenesis kits, and others), technology (topo PCR cloning, blunt end cloning, seamless cloning, and others), end use (biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the product category, cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.
Within the end use category, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.
Download sample by clicking on cloning and mutagenesis market
In terms of region, North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.
Takara Bio, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Merck, Promega, Bio-Rad Laboratories, Danaher, Jena Bioscience, Assay Genie are the major suppliers in the cloning and mutagenesis market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Compostable Plastic Packaging Market
Liquid Mosquito Repellent Market
Comments on “Lucintel Forecasts the Global Cloning and Mutagenesis Market to Reach $7.0 billion by 2030”